The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than ...

Combining ultraviolet (UV) phototherapy with the Janus kinase (JAK) inhibitor baricitinib (Olumiant) helped patients with ...

A panelist discusses how she carefully transitions patients to neurokinin-targeted therapies by establishing realistic timelines for symptom improvement and actively monitoring patient response while ...

A pair of abstracts presented at the 2024 American Society of Hematology (ASH) Annual Meeting & Exhibition suggest that ...

Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially ...

A new therapy for the most aggressive type of brain cancer can extend patients' survival while cutting the length of ...

Prostate cancer remains one of the most prevalent cancers among men worldwide. For patients with advanced or metastatic ...

You’ll likely have a few cancer treatment options. Your doctor may recommend chemo, hormone, or targeted therapy. Sometimes you may receive a combination of therapies, or something else entirely.

The consequences of primary aldosteronism mainly result from the activation of the mineralocorticoid receptor. Two of these ...